Is CollPlant Biotechnologies Ltd (CLGN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 39.7% / 30% | 153.5% / 30% | 7.5% / 30% | 143.3% / 5% | ✗ NOT HALAL |
| DJIM | 39.7% / 33% | 153.5% / 33% | 7.5% / 33% | 143.3% / 5% | ✗ NOT HALAL |
| MSCI | 16.5% / 33% | 63.7% / 33% | 3.1% / 33% | 143.3% / 5% | ✗ NOT HALAL |
| S&P | 39.7% / 33% | 153.5% / 33% | 7.5% / 33% | 143.3% / 5% | ✗ NOT HALAL |
| FTSE | 16.5% / 33% | 63.7% / 33% | 3.1% / 50% | 143.3% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 63.0% | |
| Operating Margin | -4554.5% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -92.7% | |
| Return on Assets (ROA) | -42.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$14M |
| Free Cash Flow | -$15M |
| Total Debt | $3M |
| Debt-to-Equity | 31.6 |
| Current Ratio | 3.7 |
| Total Assets | $19M |
Price & Trading
| Last Close | $0.66 |
| 50-Day MA | $0.94 |
| 200-Day MA | $1.82 |
| Avg Volume | 81K |
| Beta | 1.0 |
|
52-Week Range
$0.49
| |
About CollPlant Biotechnologies Ltd (CLGN)
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CollPlant Biotechnologies Ltd (CLGN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CollPlant Biotechnologies Ltd is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CollPlant Biotechnologies Ltd's debt ratio?
CollPlant Biotechnologies Ltd's debt ratio is 39.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 16.5%.
What are CollPlant Biotechnologies Ltd's key financial metrics?
CollPlant Biotechnologies Ltd has a market capitalization of $8M, and revenue of $515,000. Return on equity stands at -92.7%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.